Inactivating somatic ATM mutations are associated with T- and B-cell lymphoma (201, 202); dysregulated V(D)J recombination results in translocations in ATM-deficient lymphocytes, potentially promoting tumorigenesis (203, 204). This evidence concerns the gene ATM and B-cell non-Hodgkin lymphoma.